Despite progress in treatment for inflammatory bowel disease, patients and providers reported differing expectations as to remission and other aspects of disease control in a recent global survey, as presented in a poster during...
Read MoreIn this exclusive video from the GUILD Conference 2020, Adam Cheifetz, MD, from Beth Israel Deaconess Medical Center discusses his presentation on change treatment paradigms in new onset inflammatory bowel disease. Cheifetz told...
Read MoreMAUI, Hawaii — Certain inflammatory bowel disease therapies may further increase malignancies in patients with Crohn’s disease or ulcerative colitis, according to an expert at the GUILD Conference 2020. “We...
Read MoreMAUI, Hawaii — JAK inhibitors offer quick results, improved quality of life and lower serious adverse events for patients with inflammatory bowel disease, according to an expert at the GUILD Conference 2020. “JAK...
Read MoreAUSTIN, Texas — A quality improvement program that helps facilities make changes in practice structure and share best practices helped improve outcomes among patients with inflammatory bowel disease, according to research...
Read MoreAUSTIN, Texas — Incorporating electronic medical record-activated alerts in a pediatric inflammatory bowel disease center improved the detection and treatment of iron deficiency with and without anemia among patients,...
Read MoreAUSTIN, Texas — Though clinical data for nutrition as therapy in IBD is limited, physicians should not be deterred from discussing it with patients if patients participate in the decision and comply as if the diet is a...
Read MoreAUSTIN, Texas — Approximately 30% of patients with inflammatory bowel disease developed new or worsening extraintestinal manifestations after receiving Entyvio, according to data presented at Crohn’s & Colitis...
Read MoreAUSTIN, Texas — In a cycle of physician prescriptions, payer denials and repeated appeals, gastroenterologists often become advocates for their patients, according to a presenter at the Crohn’s and Colitis...
Read MoreAUSTIN, Texas — Inflammatory bowel disease can vary drastically from patient to patient. There is not a one-size-fits-all therapy that can handle all that variance. At the Crohn’s and Colitis Congress, experts...
Read More
Related ArticlesAcute Pancreatitis in a Patient With Ulcerative Colitis on Vedolizumab. Inflamm Bowel Dis. 2020 Feb 26;: Authors: Lin E, Katz S PMID: 32100867 [PubMed – as supplied by publisher] PubMed Link:...
Read MoreRelated ArticlesIdentifying IBD Providers’ Knowledge Gaps Using a Prospective Web-based Survey. Inflamm Bowel Dis. 2020 Feb 26;: Authors: Malter L, Jain A, Cohen BL, Gaidos JKJ, Axisa L, Butterfield L, Rescola BJ, Sarode...
Read MoreRelated ArticlesRisk of Venous Thromboembolism After Hospital Discharge in Patients with Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2020 Feb 25;: Authors: Dai C, Cao Q, Jiang M PMID: 32095834 [PubMed – as...
Read MoreRelated ArticlesMental Health Costs of Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2020 Feb 25;: Authors: Szigethy E, Murphy SM, Ehrlich OG, Engel-Nitz NM, Heller CA, Henrichsen K, Lawton R, Meadows P, Allen JI Abstract...
Read MoreRelated ArticlesCirculating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2020 Feb 25;: Authors: Carvalho LGF, Lima WG, Coelho LGV, Cardoso VN,...
Read MoreRelated ArticlesDevelopment of a prognostic model for one-year surgery risk in Crohn’s disease patients: A retrospective study. World J Gastroenterol. 2020 Feb 07;26(5):524-534 Authors: Yao JY, Jiang Y, Ke J, Lu Y, Hu J,...
Read MoreEfficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis. Gastroenterology. 2020 Feb 21;: Authors: Sandborn WJ, Ghosh S, Panes J, Schreiber S, D’Haens G, Tanida S, Siffledeen J, Enejosa J,...
Read MoreRelated ArticleslncRNACNN3-206 activates intestinal epithelial cell apoptosis and invasion by sponging miR-212, an implication for Crohn’s disease. World J Gastroenterol. 2020 Feb 07;26(5):478-498 Authors: Li N, Shi RH...
Read MoreToxic Epidermal Necrolysis Because of Various Herpesviruses Infection After Accelerated Infliximab Induction in a Chinese Patient With Acute Severe Ulcerative Colitis. Inflamm Bowel Dis. 2020 Feb 22;: Authors: Li H, Tian F PMID:...
Read MoreUse of an iPhone Application to Increase Adherence in Patients With Ulcerative Colitis in Remission: A Randomized Controlled Trial. Inflamm Bowel Dis. 2020 Feb 22;: Authors: Ley D, Martin B, Caldera F PMID: 32086525 [PubMed...
Read More